Shaanxi Meibang Pharmaceutical Group Co., Ltd.
- Jurisdiction
China - ISIN
CNE100005071 (605033.SS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Shaanxi Meibang Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of pesticide preparations. Read full profile
Fundamentals
- Net revenue
€102.48M - Gross margin
28.6% - EBIT
€634.27K - EBIT margin
0.6% - Net income
€2.66M - Net margin
2.6%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
CN¥0.10 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
126.2%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions